Alhemo
NDC 0169-2080, concizumab, injection, solution, from Novo Nordisk.
- Product NDC
- 0169-2080
- Status
- Listed
- Labeler
- Novo Nordisk
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761315
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0169-2080 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CONCIZUMAB100 mg/mL
Pharmacologic classes
Tissue Factor Pathway Inhibitor Antagonist [EPC]; Tissue Factor Pathway Inhibitor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0169-2080-15 | 00169208015 | 1 SYRINGE, PLASTIC in 1 CARTON (0169-2080-15) / 1.5 mL in 1 SYRINGE, PLASTIC |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/156f6404-1f6f-417f-bcf8-f07a27a82cc1Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0169-2080
Use it
Look up 0169-2080 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0169-2080 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0169-2080. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.